A new approach to identifying genetic causes of human infertility is unveiled in a new study [1]. The approach deploys computational methods to predict which human singlenucleotide polymorphisms (SNPs) are likely to be involved in infertility and uses CRISPR/Cas9 to engineer these SNPs into mice.
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A new approach to identifying genetic causes of human infertility is unveiled in a new study [1] . The approach deploys computational methods to predict which human singlenucleotide polymorphisms (SNPs) are likely to be involved in infertility and uses CRISPR/Cas9 to engineer these SNPs into mice.
Infertility affects about 15 percent of couples of childbearing age, and a large proportion of these cases are thought to have a genetic basis. Infertility is genetically complex, and identifying mutations involved is particularly challenging-for instance, genetic pedigrees are stunted by childlessness.
The new experimental strategy is designed to circumvent these issues. Priti Singh and John Schimenti assessed genes known to be involved in meiosis and that have an infertility phenotype when knocked out in mice. They then identified potential SNPs in these genes involved in human fertility by applying the following criteria: 1) the SNPs exist as lowfrequency alleles in humans; 2) the SNPs alter evolutionary, conserved amino acids; and 3) the SNP is predicted to be deleterious, as assessed by multiple computational tools.
Using this method, the researchers identified four SNPs in four separate genes involved in meiosis. They then generated these SNPs in mice using CRISPR/Cas9 and assessed the mice for infertility and associated phenotypes such as low sperm count. Only one of the SNPs-affecting CDK2 (Cyclindependent kinase 2)-had a phenotype. The female homozygous mice were fertile, but the male homozygous mice had tiny testes and severely disrupted spermatogenesis. The heterozyotes had a less severe phenotype.
This rare SNP has been identified in only 2 of 688 CDK2 alleles sampled, and the findings in mice suggest how its unique genetics may allow it to persist in the human population. Unaffected females may pass the allele to their male offspring-which may only have a severe phenotype if they are homozygous, and would be expected to occur at a rate of only 1 in 236,672.
The new strategy has the potential to be used in establishing a database of deleterious vs. benign alleles of genes involved in fertility, and to be applied more broadly to other genetic conditions.
